about
Variant of TREM2 Associated with the Risk of Alzheimer's DiseaseRate of de novo mutations and the importance of father's age to disease riskGenomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical PracticeGetting Ready for the Dance: FANCJ Irons Out DNA WrinklesInterplay between Fanconi anemia and homologous recombination pathways in genome integrityUpdate of the human and mouse Fanconi anemia genesRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerOvarian cancer biomarker discovery based on genomic approachesMolecular functions and cellular roles of the ChlR1 (DDX11) helicase defective in the rare cohesinopathy Warsaw breakage syndromeEmerging critical roles of Fe-S clusters in DNA replication and repair.Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomasChl1 DNA helicase regulates Scc2 deposition specifically during DNA-replication in Saccharomyces cerevisiae.Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatmentHomologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteinsGenetic testing for RAD51C mutations: in the clinic and communityContribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationFanconi anaemia and the repair of Watson and Crick DNA crosslinksGenomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolateEvolution of the cancer genomeDiscovery of common variants associated with low TSH levels and thyroid cancer riskInherited Mutations in Women With Ovarian CarcinomaHereditary breast cancer: ever more pieces to the polygenic puzzle.Insight into the roles of helicase motif Ia by characterizing Fanconi anemia group J protein (FANCJ) patient mutationsSequence variant at 4q25 near PITX2 associates with appendicitis.Counselling framework for moderate-penetrance cancer-susceptibility mutations.The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.Loss of BRCA1-A complex function in RAP80 null tumor cellsMolecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemiaCase-control association mapping by proxy using family history of disease.Absence of DICER1, CTCF, RPL22, DNMT3A, TRRAP, IDH1 and IDH2 hotspot mutations in patients with various subtypes of ovarian carcinomas.Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.Genetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets.Telomere-regulating genes and the telomere interactome in familial cancers.Inferring polymorphism-induced regulatory gene networks active in human lymphocyte cell lines by weighted linear mixed model analysis of multiple RNA-Seq datasets.Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high riskEvolutionary patterns of DNA base composition and correlation to polymorphisms in DNA repair systemsTumour spectrum in non-BRCA hereditary breast cancer families in SwedenA risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsBRCA1 tumor suppressor network: focusing on its tail.Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells.
P2860
Q22250874-94EE12A9-0BB6-4A2F-81E7-560726EA592DQ24632353-4A1EF12D-6A30-46F1-8C92-C328AF63E9F3Q26740622-1189D0D5-437A-47A8-9757-D9375AACC2E9Q26744714-56AF60C9-8720-433E-A027-0C69648620D3Q26753126-B9FA4360-A3B0-4E00-A8A6-98EE660DF1D4Q26776461-2E42A4A4-9C46-4819-90A3-86C4B01AA582Q26780387-915A38AE-8B75-4D28-B60E-A52B141F28C1Q27013687-E5933869-DC61-491B-BC00-41984EB03D4DQ27016169-EEFB9469-93CC-4BB4-B2E6-E0ABE0352873Q27332013-D172F441-9F56-4659-B53D-BA302B25AC3EQ27852671-6874D9F8-F3C2-4FBB-9953-6EC5558BF09BQ27938640-4C15A813-E7B5-4237-9A7D-C6A1EC2D201AQ28075761-766A73A3-A41F-4130-B574-CE71EAA136BCQ28085364-E76B4A87-83A7-46F2-8C8B-24D716E0C959Q28253197-28709E8A-F462-4016-897C-499A9FE7CFDDQ28266112-0DC2E448-5783-4CB0-AA7D-E7AEE6D95EA9Q28283549-9A7525FD-69E0-4673-91CD-DFF6AAD34036Q28657831-CAA5C73F-53BA-4CAB-9484-5B4DA7B3A8ACQ28678232-AE0CFF48-4F9F-4425-A87A-E570A9F35132Q28943471-B3A0D481-9D2C-4B55-A2D2-CF18DA2EBC70Q30353433-099CE6A0-5076-4921-894C-03163DB200F9Q33356511-F8795581-61EE-4EFD-9AB8-E7F42EE802ABQ33675765-252DC722-D403-44B5-9095-72674B48A926Q33780039-7F61A58C-75B2-4E51-A6FA-7018BB8829B7Q33911135-02551AAC-D983-42A9-98E7-6B64F848B4D5Q33991747-68F4C18C-12D5-467C-979A-2A67D2C8B578Q34336205-FC3E81B6-F114-4507-9274-2E41F2581447Q34377302-E0CBA15E-DDB6-4126-A3EE-6FCB23D2CDA3Q34549400-BCD8E488-8D76-4434-B6BD-45AEB5D94F8CQ34607312-48B14BD7-FE7B-44DC-9CD7-8435333956E6Q34650062-FF1A64F4-8D61-41D9-A8B8-E9360267AF37Q34765381-44D97043-B532-445E-BD5D-3B697900C961Q34784471-6CF79626-2575-4598-ADA9-C9EF19049AEAQ35036788-ADD552C3-D8AA-47D2-B9BC-2337DEF4654FQ35164851-F0E7B1DE-C476-4C9F-BC30-85E9F3EB4F8FQ35476330-73CFF664-42BA-4C89-971F-4F6A7BE8CD70Q35747645-A008E236-5467-479F-9B00-E3336A07326CQ35848518-C6F3C9F6-B9A5-4646-ACDE-608BD5B3B51FQ35861690-BAA768BB-6354-4EC3-98C8-78F8740E92DAQ35986590-5CB4C821-DF40-4E99-B0F8-F78B3F46222A
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mutations in BRIP1 confer high risk of ovarian cancer
@ast
Mutations in BRIP1 confer high risk of ovarian cancer
@en
Mutations in BRIP1 confer high risk of ovarian cancer
@nl
type
label
Mutations in BRIP1 confer high risk of ovarian cancer
@ast
Mutations in BRIP1 confer high risk of ovarian cancer
@en
Mutations in BRIP1 confer high risk of ovarian cancer
@nl
prefLabel
Mutations in BRIP1 confer high risk of ovarian cancer
@ast
Mutations in BRIP1 confer high risk of ovarian cancer
@en
Mutations in BRIP1 confer high risk of ovarian cancer
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Mutations in BRIP1 confer high risk of ovarian cancer
@en
P2093
Ana de Juan
Angeles Panadero
Anna Salvarsdottir
Anne M van Altena
Arnaldur Gylfason
Asgeir Sigurdsson
Carlos Mayordomo
Eugenia Ortega
Fernando Rivera
Gisli Masson
P2860
P2888
P304
P3181
P356
10.1038/NG.955
P407
P50
P577
2011-10-02T00:00:00Z
P6179
1019958453